BNP Paribas Decreases Stake in McKesson Corporation $MCK

Institutional investor reduces holding in pharmaceutical distributor

Mar. 15, 2026 at 9:08am

Got story updates? Submit your updates here. ›

According to a recent SEC filing, BNP Paribas has decreased its stake in McKesson Corporation (NYSE:MCK) by 3.0% during the 3rd quarter. The fund now owns 51,667 shares of the company's stock, making it the 21st largest position in its portfolio.

Why it matters

As a major institutional investor, changes in BNP Paribas' holdings in McKesson are noteworthy and could signal broader market sentiment around the pharmaceutical distribution company. McKesson is a key player in the healthcare supply chain, so fluctuations in ownership by large investors are worth monitoring.

The details

In its most recent 13F filing with the SEC, BNP Paribas reported selling 1,592 shares of McKesson during the 3rd quarter. The firm now owns 51,667 shares of the company's stock, valued at $39,590,000 as of the filing date. McKesson makes up about 1.2% of BNP Paribas' total portfolio.

  • BNP Paribas decreased its stake in McKesson during the 3rd quarter of 2026.

The players

BNP Paribas

A major French multinational bank and financial services company.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in BNP Paribas' stake in McKesson, while relatively small, could indicate broader market uncertainty around the pharmaceutical distribution industry or specific concerns about McKesson's performance. Investors will be watching to see if other large institutions follow suit or if BNP Paribas continues to trim its position in the coming quarters.